Jing‐Jing Liu

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu, Xu-Hua Guan, Yu-Hua Li et al. · The Lancet · 2020 · 1.3K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Construction of a Quadruple Auxotrophic Mutant of an Industrial Polyploid Saccharomyces cerevisiae Strain by Using RNA-Guided Cas9 Nuclease

Guo-Chang Zhang, In Iok Kong, Heejin Kim et al. · Applied and Environmental Microbiology · 2014 · 175 citations · Full text

Life Sciences, Biotechnology, Genetics +15

Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae

Sora Yu, Jing‐Jing Liu, Eun Ju Yun et al. · Microbial Cell Factories · 2018 · 116 citations · Full text

Life Sciences, Biotechnology, Microbiology +10

Overcoming the thermodynamic equilibrium of an isomerization reaction through oxidoreductive reactions for biotransformation

Jing‐Jing Liu, Guo-Chang Zhang, Suryang Kwak et al. · Nature Communications · 2019 · 91 citations · Full text

Engineering, Bioengineering, Biotechnology +17

Recycling Carbon Dioxide during Xylose Fermentation by Engineered <i>Saccharomyces cerevisiae</i>

Peng‐Fei Xia, Guo-Chang Zhang, Berkley J. Walker et al. · ACS Synthetic Biology · 2016 · 78 citations

Life Sciences, Biotechnology, Microbiology +17